The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18. Sales increased 8.6% year-over-year to ...

In February 2026, Labcorp Holdings Inc. reported past fourth-quarter 2025 sales of US$3,515.8 million and net income of US$164.7 million, alongside full-year 2025 sales of US$13.95 billion and net ...

Good day and thank you for standing by. Welcome to the Q1 2025 Labcorp Holdings Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, ...

Adam Schechter, President, CEO & Chairman, stated that "during the quarter, we delivered strong revenue growth and margin improvement, leading to double-digit EPS growth." He highlighted continued ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...

BURLINGTON, N.C., March 31, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first ...

根据向美国证券交易委员会提交的Form 4文件,Labcorp Holdings Inc(纽交所代码:LH)企业事务执行副总裁Sandra D. van der Vaart于2026年2月27日出售了547.5397股普通股。 这些股票的出售价格为284.91美元,交易总价值为155,999美元。交易完成后,van der Vaart直接持有Labcorp Holdings Inc 2578.94 ...

Labcorp Holdings Inc (纽交所代码:LH)总裁兼首席执行官Adam H. Schechter于2026年3月3日以每股$279.9595的价格出售了8,705股普通股,交易总额约为244万美元。此次交易后,Schechter直接持有Labcorp 80,773股股票。此次出售正值Labcorp股价接近其52周高点$293.72,今年迄今股价上涨12%。该股目前市盈率为26.91 ...